$FGEN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in FIBROGEN INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in FIBROGEN INC. Get notifications about new insider transactions in FIBROGEN INC for free.
Page: < prev 1 ... 4 5 6 7 8 9 10 11 12 ... 14 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 52.21 | 2,900 | 151,409 | 21,100 | 24 K to 21.1 K (-12.08 %) |
| Mar 16 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Buy | M | 2.90 | 4,000 | 11,600 | 24,000 | 20 K to 24 K (+20.00 %) |
| Mar 15 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Option Exercise | M | 18.34 | 12,000 | 220,080 | 0 | |
| Mar 15 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Option Exercise | M | 18.00 | 12,000 | 216,000 | 0 | |
| Mar 15 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Sell | S | 53.53 | 9,844 | 526,949 | 48,000 | 57.8 K to 48 K (-17.02 %) |
| Mar 15 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Sell | S | 53.26 | 14,156 | 753,949 | 57,844 | 72 K to 57.8 K (-19.66 %) |
| Mar 15 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Buy | M | 18.34 | 12,000 | 220,080 | 72,000 | 60 K to 72 K (+20.00 %) |
| Mar 15 2018 | FGEN | FIBROGEN INC | Tamura Toshinari | Director | Buy | M | 18.00 | 12,000 | 216,000 | 60,000 | 48 K to 60 K (+25.00 %) |
| Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Option Exercise | M | 19.39 | 14,000 | 271,460 | 46,000 | |
| Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Option Exercise | M | 29.66 | 22,094 | 655,308 | 20,042 | |
| Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Option Exercise | A | 53.75 | 38,000 | 2,042,500 | 38,000 | |
| Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 53.08 | 13,804 | 732,716 | 196,334 | 210.1 K to 196.3 K (-6.57 %) |
| Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 52.23 | 22,290 | 1,164,207 | 210,138 | 232.4 K to 210.1 K (-9.59 %) |
| Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Buy | M | 29.66 | 22,094 | 655,308 | 232,428 | 210.3 K to 232.4 K (+10.50 %) |
| Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Buy | M | 19.39 | 14,000 | 271,460 | 210,334 | 196.3 K to 210.3 K (+7.13 %) |
| Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Grant | A | 0.00 | 28,000 | 0 | 196,334 | 168.3 K to 196.3 K (+16.63 %) |
| Mar 15 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 54.61 | 5,932 | 323,947 | 168,334 | 174.3 K to 168.3 K (-3.40 %) |
| Mar 14 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 55.19 | 2,618 | 144,487 | 379,200 | 381.8 K to 379.2 K (-0.69 %) |
| Mar 14 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 54.90 | 4,382 | 240,572 | 381,818 | 386.2 K to 381.8 K (-1.13 %) |
| Mar 14 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 53.07 | 5,402 | 286,684 | 386,200 | 391.6 K to 386.2 K (-1.38 %) |
| Mar 14 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 54.98 | 19,693 | 1,082,721 | 391,602 | 411.3 K to 391.6 K (-4.79 %) |
| Mar 13 2018 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Option Exercise | M | 3.60 | 6,000 | 21,600 | 0 | |
| Mar 13 2018 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Option Exercise | M | 3.60 | 12,000 | 43,200 | 0 | |
| Mar 13 2018 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Sell | S | 55.00 | 18,000 | 990,000 | 135,064 | 153.1 K to 135.1 K (-11.76 %) |
| Mar 13 2018 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Buy | M | 3.60 | 18,000 | 64,800 | 153,064 | 135.1 K to 153.1 K (+13.33 %) |
| Mar 13 2018 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Gift | G | 0.00 | 500 | 0 | 135,064 | 135.6 K to 135.1 K (-0.37 %) |
| Mar 09 2018 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Sell | S | 55.75 | 22,905 | 1,276,954 | 411,295 | 434.2 K to 411.3 K (-5.28 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Payment of Exercise | F | 53.55 | 5,065 | 271,231 | 138,224 | 143.3 K to 138.2 K (-3.53 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 3.60 | 3,314 | 11,930 | 472,145 | |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 2.35 | 7,005 | 16,462 | 0 | |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 2.35 | 10,265 | 24,123 | 7,005 | |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 53.59 | 618 | 33,119 | 120,498 | 121.1 K to 120.5 K (-0.51 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 52.55 | 300 | 15,765 | 121,116 | 121.4 K to 121.1 K (-0.25 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 54.09 | 700 | 37,863 | 2,890,209 | 2.9 M to 2.9 M (-0.02 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 53.44 | 11,800 | 630,592 | 2,890,909 | 2.9 M to 2.9 M (-0.41 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 52.74 | 6,400 | 337,536 | 2,902,709 | 2.9 M to 2.9 M (-0.22 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 3.60 | 3,314 | 11,930 | 2,909,109 | 2.9 M to 2.9 M (+0.11 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 2.35 | 7,005 | 16,462 | 2,905,795 | 2.9 M to 2.9 M (+0.24 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 53.91 | 218 | 11,752 | 121,416 | 121.6 K to 121.4 K (-0.18 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 52.82 | 700 | 36,974 | 121,634 | 122.3 K to 121.6 K (-0.57 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 54.14 | 2,298 | 124,414 | 2,898,790 | 2.9 M to 2.9 M (-0.08 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 53.26 | 7,800 | 415,428 | 2,901,088 | 2.9 M to 2.9 M (-0.27 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 52.58 | 8,802 | 462,809 | 2,908,888 | 2.9 M to 2.9 M (-0.30 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 2.35 | 10,265 | 24,123 | 2,917,690 | 2.9 M to 2.9 M (+0.35 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Payment of Exercise | F | 53.55 | 16,199 | 867,456 | 2,907,425 | 2.9 M to 2.9 M (-0.55 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 54.47 | 79 | 4,303 | 174,266 | 174.3 K to 174.3 K (-0.05 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 53.45 | 909 | 48,586 | 174,345 | 175.3 K to 174.3 K (-0.52 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 52.68 | 906 | 47,728 | 175,254 | 176.2 K to 175.3 K (-0.51 %) |
| Mar 08 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Payment of Exercise | F | 53.55 | 5,832 | 312,304 | 176,160 | 182 K to 176.2 K (-3.20 %) |
| Mar 05 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Payment of Exercise | F | 54.95 | 1,297 | 71,270 | 143,289 | 144.6 K to 143.3 K (-0.90 %) |
| Mar 05 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Payment of Exercise | F | 54.95 | 4,455 | 244,802 | 2,923,624 | 2.9 M to 2.9 M (-0.15 %) |
| Mar 05 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Payment of Exercise | F | 54.95 | 1,860 | 102,207 | 181,992 | 183.9 K to 182 K (-1.01 %) |
| Feb 23 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 2.35 | 10,265 | 24,123 | 17,270 | |
| Feb 23 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Option Exercise | M | 2.35 | 10,265 | 24,123 | 27,535 | |
| Feb 23 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 57.11 | 418 | 23,872 | 122,334 | 122.8 K to 122.3 K (-0.34 %) |
| Feb 23 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 55.79 | 500 | 27,895 | 122,752 | 123.3 K to 122.8 K (-0.41 %) |
| Feb 23 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 57.40 | 1,000 | 57,400 | 2,928,079 | 2.9 M to 2.9 M (-0.03 %) |
| Feb 23 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 56.89 | 6,500 | 369,785 | 2,929,079 | 2.9 M to 2.9 M (-0.22 %) |
| Feb 23 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 55.90 | 11,400 | 637,260 | 2,935,579 | 2.9 M to 2.9 M (-0.39 %) |
| Feb 23 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 2.35 | 10,265 | 24,123 | 2,946,979 | 2.9 M to 2.9 M (+0.35 %) |
| Feb 23 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 57.72 | 300 | 17,316 | 123,252 | 123.6 K to 123.3 K (-0.24 %) |
| Feb 23 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 56.50 | 618 | 34,917 | 123,552 | 124.2 K to 123.6 K (-0.50 %) |
| Feb 23 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 58.03 | 100 | 5,803 | 2,936,714 | 2.9 M to 2.9 M (0.00 %) |
| Feb 23 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 57.43 | 10,051 | 577,229 | 2,936,814 | 2.9 M to 2.9 M (-0.34 %) |
| Feb 23 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 56.50 | 8,749 | 494,319 | 2,946,865 | 3 M to 2.9 M (-0.30 %) |
| Feb 23 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 2.35 | 10,265 | 24,123 | 2,955,614 | 2.9 M to 3 M (+0.35 %) |
| Feb 23 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Buy | M | 4.03 | 24,844 | 99,997 | 2,945,349 | 2.9 M to 2.9 M (+0.85 %) |
| Feb 16 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Option Exercise | M | 3.50 | 6,000 | 21,000 | 0 | |
| Feb 16 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Option Exercise | M | 3.50 | 6,000 | 21,000 | 6,000 | |
| Feb 16 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Sell | S | 56.27 | 1,400 | 78,778 | 127,840 | 129.2 K to 127.8 K (-1.08 %) |
| Feb 16 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Sell | S | 55.55 | 4,600 | 255,530 | 129,240 | 133.8 K to 129.2 K (-3.44 %) |
| Feb 16 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Buy | M | 3.50 | 6,000 | 21,000 | 133,840 | 127.8 K to 133.8 K (+4.69 %) |
| Feb 16 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Sell | S | 55.50 | 2,900 | 160,950 | 127,840 | 130.7 K to 127.8 K (-2.22 %) |
| Feb 16 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Sell | S | 54.62 | 1,907 | 104,160 | 130,740 | 132.6 K to 130.7 K (-1.44 %) |
| Feb 16 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Sell | S | 53.77 | 1,193 | 64,148 | 132,647 | 133.8 K to 132.6 K (-0.89 %) |
| Feb 16 2018 | FGEN | FIBROGEN INC | Routti Jorma | Director | Buy | M | 3.50 | 6,000 | 21,000 | 133,840 | 127.8 K to 133.8 K (+4.69 %) |
| Feb 16 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Option Exercise | M | 9.78 | 1,000 | 9,775 | 10,000 | |
| Feb 16 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Sell | S | 56.29 | 300 | 16,887 | 29,000 | 29.3 K to 29 K (-1.02 %) |
| Feb 16 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Sell | S | 55.73 | 700 | 39,011 | 29,300 | 30 K to 29.3 K (-2.33 %) |
| Feb 16 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Buy | M | 9.78 | 1,000 | 9,775 | 30,000 | 29 K to 30 K (+3.45 %) |
| Feb 16 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Option Exercise | M | 18.00 | 3,960 | 71,280 | 3,500 | |
| Feb 16 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Option Exercise | M | 29.66 | 22,000 | 652,520 | 42,136 | |
| Feb 16 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Option Exercise | M | 18.00 | 23,540 | 423,720 | 7,460 | |
| Feb 16 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 56.76 | 560 | 31,786 | 183,852 | 184.4 K to 183.9 K (-0.30 %) |
| Feb 16 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 56.20 | 3,400 | 191,080 | 184,412 | 187.8 K to 184.4 K (-1.81 %) |
| Feb 16 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Buy | M | 18.00 | 3,960 | 71,280 | 187,812 | 183.9 K to 187.8 K (+2.15 %) |
| Feb 16 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 56.94 | 3,700 | 210,678 | 183,852 | 187.6 K to 183.9 K (-1.97 %) |
| Feb 16 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 56.29 | 23,730 | 1,335,762 | 187,552 | 211.3 K to 187.6 K (-11.23 %) |
| Feb 16 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 55.35 | 16,210 | 897,224 | 211,282 | 227.5 K to 211.3 K (-7.13 %) |
| Feb 16 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 54.50 | 1,900 | 103,550 | 227,492 | 229.4 K to 227.5 K (-0.83 %) |
| Feb 16 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Buy | M | 29.66 | 22,000 | 652,520 | 229,392 | 207.4 K to 229.4 K (+10.61 %) |
| Feb 16 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Buy | M | 18.00 | 23,540 | 423,720 | 207,392 | 183.9 K to 207.4 K (+12.80 %) |
| Feb 16 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Option Exercise | M | 2.90 | 6,000 | 17,400 | 0 | |
| Feb 16 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 56.25 | 1,100 | 61,875 | 20,000 | 21.1 K to 20 K (-5.21 %) |
| Feb 16 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 55.56 | 4,900 | 272,244 | 21,100 | 26 K to 21.1 K (-18.85 %) |
| Feb 16 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Buy | M | 2.90 | 6,000 | 17,400 | 26,000 | 20 K to 26 K (+30.00 %) |
| Feb 09 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Sell | S | 54.51 | 400 | 21,804 | 144,586 | 145 K to 144.6 K (-0.28 %) |
| Feb 09 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Sell | S | 53.94 | 7,100 | 382,974 | 144,986 | 152.1 K to 145 K (-4.67 %) |
| Jan 31 2018 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Sell | S | 62.00 | 10,000 | 620,000 | 152,086 | 162.1 K to 152.1 K (-6.17 %) |
| Jan 31 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 61.28 | 418 | 25,615 | 124,170 | 124.6 K to 124.2 K (-0.34 %) |
| Jan 31 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 62.49 | 200 | 12,498 | 2,920,505 | 2.9 M to 2.9 M (-0.01 %) |
| Jan 31 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 61.54 | 8,700 | 535,398 | 2,920,705 | 2.9 M to 2.9 M (-0.30 %) |
| Jan 31 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 60.81 | 10,000 | 608,100 | 2,929,405 | 2.9 M to 2.9 M (-0.34 %) |
| Jan 31 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 61.64 | 418 | 25,766 | 124,588 | 125 K to 124.6 K (-0.33 %) |
| Jan 31 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 62.43 | 400 | 24,972 | 2,939,405 | 2.9 M to 2.9 M (-0.01 %) |
| Jan 31 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 61.82 | 13,800 | 853,116 | 2,939,805 | 3 M to 2.9 M (-0.47 %) |
| Jan 31 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 61.06 | 4,500 | 274,770 | 2,953,605 | 3 M to 3 M (-0.15 %) |
| Jan 31 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 59.30 | 200 | 11,860 | 2,958,105 | 3 M to 3 M (-0.01 %) |
| Jan 30 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Sell | S | 60.00 | 6,000 | 360,000 | 29,000 | 35 K to 29 K (-17.14 %) |
| Jan 24 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Sell | S | 50.00 | 1,929 | 96,450 | 35,000 | 36.9 K to 35 K (-5.22 %) |
| Jan 24 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Sell | S | 50.00 | 71 | 3,550 | 36,929 | 37 K to 36.9 K (-0.19 %) |
| Jan 24 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Option Exercise | M | 18.00 | 25,000 | 450,000 | 31,000 | |
| Jan 24 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 49.11 | 13,198 | 648,154 | 183,852 | 197.1 K to 183.9 K (-6.70 %) |
| Jan 24 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 48.28 | 11,802 | 569,801 | 197,050 | 208.9 K to 197.1 K (-5.65 %) |
| Jan 24 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Buy | M | 18.00 | 25,000 | 450,000 | 208,852 | 183.9 K to 208.9 K (+13.60 %) |
| Jan 24 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Sell | S | 50.00 | 1,929 | 96,450 | 35,000 | 36.9 K to 35 K (-5.22 %) |
| Jan 24 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Sell | S | 50.00 | 71 | 3,550 | 36,929 | 37 K to 36.9 K (-0.19 %) |
| Jan 24 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Option Exercise | M | 18.00 | 25,000 | 450,000 | 31,000 | |
| Jan 24 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 49.11 | 13,198 | 648,154 | 183,852 | 197.1 K to 183.9 K (-6.70 %) |
| Jan 24 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Sell | S | 48.28 | 11,802 | 569,801 | 197,050 | 208.9 K to 197.1 K (-5.65 %) |
| Jan 24 2018 | FGEN | FIBROGEN INC | Cotroneo Pat | VP, Finance and CFO | Buy | M | 18.00 | 25,000 | 450,000 | 208,852 | 183.9 K to 208.9 K (+13.60 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Option Exercise | M | 9.78 | 1,000 | 9,775 | 11,000 | |
| Jan 19 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Sell | S | 48.15 | 1,000 | 48,145 | 37,000 | 38 K to 37 K (-2.63 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Sell | S | 47.31 | 5,000 | 236,550 | 38,000 | 43 K to 38 K (-11.63 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Buy | M | 9.78 | 1,000 | 9,775 | 43,000 | 42 K to 43 K (+2.38 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 47.11 | 418 | 19,692 | 125,006 | 125.4 K to 125 K (-0.33 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 47.68 | 3,700 | 176,416 | 2,958,305 | 3 M to 3 M (-0.12 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 47.18 | 15,200 | 717,136 | 2,962,005 | 3 M to 3 M (-0.51 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 47.51 | 418 | 19,859 | 125,424 | 125.8 K to 125.4 K (-0.33 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 47.92 | 4,242 | 203,277 | 2,977,205 | 3 M to 3 M (-0.14 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 47.56 | 14,658 | 697,134 | 2,981,447 | 3 M to 3 M (-0.49 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Option Exercise | M | 2.90 | 6,000 | 17,400 | 6,000 | |
| Jan 19 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 47.99 | 600 | 28,794 | 22,000 | 22.6 K to 22 K (-2.65 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 47.31 | 5,400 | 255,474 | 22,600 | 28 K to 22.6 K (-19.29 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | M | 2.90 | 6,000 | 17,400 | 28,000 | 34 K to 28 K (-17.65 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Option Exercise | M | 9.78 | 1,000 | 9,775 | 11,000 | |
| Jan 19 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Sell | S | 48.15 | 1,000 | 48,145 | 37,000 | 38 K to 37 K (-2.63 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Sell | S | 47.31 | 5,000 | 236,550 | 38,000 | 43 K to 38 K (-11.63 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Buy | M | 9.78 | 1,000 | 9,775 | 43,000 | 42 K to 43 K (+2.38 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 47.11 | 418 | 19,692 | 125,006 | 125.4 K to 125 K (-0.33 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 47.68 | 3,700 | 176,416 | 2,958,305 | 3 M to 3 M (-0.12 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 47.18 | 15,200 | 717,136 | 2,962,005 | 3 M to 3 M (-0.51 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 47.51 | 418 | 19,859 | 125,424 | 125.8 K to 125.4 K (-0.33 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 47.92 | 4,242 | 203,277 | 2,977,205 | 3 M to 3 M (-0.14 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 47.56 | 14,658 | 697,134 | 2,981,447 | 3 M to 3 M (-0.49 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Option Exercise | M | 2.90 | 6,000 | 17,400 | 6,000 | |
| Jan 19 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 47.99 | 600 | 28,794 | 22,000 | 22.6 K to 22 K (-2.65 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 47.31 | 5,400 | 255,474 | 22,600 | 28 K to 22.6 K (-19.29 %) |
| Jan 19 2018 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | M | 2.90 | 6,000 | 17,400 | 28,000 | 34 K to 28 K (-17.65 %) |
| Jan 08 2018 | FGEN | FIBROGEN INC | Neff Thomas B | Chief Executive Off ... | Sell | S | 45.84 | 418 | 19,161 | 125,842 | 126.3 K to 125.8 K (-0.33 %) |